한글목차

페닐부티르산나트륨 시장은 2025년에는 21억 9,000만 달러, 2032년에는 34억 5,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지의 CAGR은 6.7%를 나타낼 전망입니다.

페닐부티르산나트륨(SPB)는 의학 연구 및 치료 접근법에서 큰 관심을 끌고있는 주목할만한 의약 화합물입니다. 페닐부티르산의 유도체로서, SPB는 광범위한 치료 특성을 나타내며 다양한 병리학에 대한 유망한 후보가 됩니다. SPB의 주요 용도는 우레아 사이클 장애의 관리이며, 암모니아를 효과적으로 배출하는 신체의 능력이 손상되는 유전 질환입니다. 또한 현재 진행중인 연구에서는 신경 퇴행성 질환과 암을 완화시킬 가능성이 모색되고 있습니다. 이 소개는 나트륨 페닐 부티레이트가 의학의 발전과 환자 관리의 향상을 이루는 중요한 역할에 빛을 발하는 것을 목표로 합니다.

시장 역학 :

우레아 사이클 장애(UCD)의 유병률 증가, 희귀질환에 대한 인식과 진단 증가, 오판 약물 개발의 확대는 예측 기간 중 페닐부티르산 나트륨 세계 시장의 성장을 가속할 것으로 예측됩니다. 국가 시장으로의 개척, 병용 요법의 개발, 적응증의 확대, 정밀의료에 대한 주목의 고조는 예측 기간 중에 페닐부티르산나트륨 세계 시장에 성장 기회를 가져올 것으로 예측됩니다.

그러나 제한된 인지도와 과소진단, 높은 치료비, 엄격한 규제 요건, 부작용 및 안전성에 대한 우려가 예측 기간 동안 페닐부티르산나트륨 시장의 성장을 방해할 것으로 예측됩니다.

본 조사의 주요 특징

• 페닐부티르산나트륨 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간 2025년-2032년 시장 규모 및 복합연간 성장률(CAGR%)을 제공합니다.
• 또, 다양한 부문에 걸친 잠재적인 수익 기회를 해명해, 이 시장의 매력적인 투자 제안의 매트릭스에 대해서 설명하고 있습니다.
• 또 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
• 본 보고서에서는 페닐부티르산나트륨 시장의 주요 기업 프로파일을 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 실적, 전략 등의 파라미터에 근거하여 제공합니다.
• 본 보고서로부터의 통찰에 의해 마케팅 담당자나 기업의 경영진은 장래의 제품 발매, 유형 업, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
• 페닐 부티르산 나트륨 시장 보고서는 투자자, 공급업체, 제품 제조 업체, 유통 업체, 신규 참가자, 재무 분석가 등이 업계의 다양한 이해 관계자에 대응하고 있습니다.
• 이해관계자는 페닐부티르산나트륨 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
• 우레아 사이클 이상증(UCD)의 유병률 증가
  • 억제요인
• 인식 부족과 진단 부족
  • 기회
• 신흥 시장 진출
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 출시/승인
• PEST 분석
• PORTER 분석
• 합병과 인수 시나리오

제4장 페닐부티르산나트륨 시장, 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측의 분석
• 경제에 미치는 영향

제5장 페닐부티르산나트륨 시장, 용도별, 2020-2032년

• 의약품
• 식음료
• 기타

제6장 페닐부티르산나트륨 시장, 유통채널별, 2020년-2032년

• 직접 판매
• 리셀러 판매
• 온라인 소매

제7장 페닐부티르산나트륨 시장, 최종 사용자별, 2020-2032년

• 병원 및 진료소
• 연구기관
• 식음료 업계
• 화장품 업계
• 기타 산업

제8장 페닐부티르산나트륨 시장, 지역별, 2020-2032년

• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 영국
  • 스페인
  • 프랑스
  • 이탈리아
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 호주
  • 한국
  • ASEAN
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 아르헨티나
  • 멕시코
  • 기타 라틴아메리카
• 중동 및 아프리카
  • GCC 국가
  • 이스라엘
  • 남아프리카
  • 북아프리카
  • 중앙 아프리카
  • 기타 중동

제9장 경쟁 구도

• Horizon Therapeutics plc
• Ammonett Pharma LLC
• Medison Pharma Ltd.
• Synageva BioPharma Corp.
• Swedish Orphan Biovitrum AB(Sobi)
• Entera Health, Inc.
• Dipharma Francis SrI
• Uncyclyd Pharma, Inc.

제10장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Sodium Phenylbutyrate Market is estimated to be valued at USD 2.19 Bn in 2025 and is expected to reach USD 3.45 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2032.

Sodium phenylbutyrate (SPB) is a notable pharmaceutical compound that has garnered significant attention in medical research and treatment approaches. As a derivative of phenylbutyric acid, SPB exhibits a wide array of therapeutic properties, making it a promising candidate for various medical conditions. Its primary application lies in the management of urea cycle disorders, a group of genetic conditions that impair the body's ability to eliminate ammonia effectively. Additionally, ongoing studies are exploring its potential for mitigating neurodegenerative diseases and cancer. This introduction aims to shed light on the essential role of sodium phenylbutyrate in advancing medical science and enhancing patient care.

Market Dynamics:

The increasing prevalence of urea cycle disorders (UCDs), growing awareness and diagnosis of rare diseases, and the expansion of orphan drug development are anticipated to drive growth of the global sodium phenylbutyrate market over the forecast period. Moreover, advancements in pharmaceutical research and development are also expected to boost the growth of the global sodium phenylbutyrate market over the forecast period. Expansion into emerging markets, development of combination therapies, expansion of indications, and increasing focus on precision medicine are expected to create growth opportunities for the global sodium phenylbutyrate market during the forecast period. The increasing prevalence of urea cycle disorders and cancer globally is driving the demand for effective treatments, which in turn is expected to boost the market growth for sodium phenylbutyrate.

However, limited awareness and underdiagnosis, high treatment costs, stringent regulatory requirements and side effects and safety concerns are expected to hamper growth of the sodium phenylbutyrate market over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the sodium phenylbutyrate market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the sodium phenylbutyrate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Horizon Therapeutics plc, Ammonett Pharma LLC, Medison Pharma Ltd., Modern Dietetics Inc., Synageva BioPharma Corp., Medison Pharma Ltd., Swedish Orphan Biovitrum AB (Sobi), Entera Health, Inc., Dipharma Francis S.r.l., Ucyclyd Pharma, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The sodium phenylbutyrate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the sodium phenylbutyrate market

Sodium Phenylbutyrate Market Detailed Segmentation:

• By Application:
  • Pharmaceutical
  • Food & Beverages
  • Others
• By Distribution Channel:
  • Direct Sales
  • Distributor Sales
  • Online Retail
• By End User:
  • Hospitals and Clinics
  • Research Institutes
  • Food & Beverage Industry
  • Cosmetics Industry
  • Other Industries
• By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profile:
  • Horizon Therapeutics plc
  • Ammonett Pharma LLC
  • Medison Pharma Ltd.
  • Synageva BioPharma Corp.
  • Swedish Orphan Biovitrum AB (Sobi)
  • Entera Health, Inc.
  • Dipharma Francis S.r.l.
  • Ucyclyd Pharma, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Sodium Phenylbutyrate , By Application
  • Market Sodium Phenylbutyrate , By Distribution Channel
  • Market Sodium Phenylbutyrate , By End User
  • Market Sodium Phenylbutyrate , By region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing prevalence of urea cycle disorders (UCDs)
  • Restraints
• Limited awareness and underdiagnosis
  • Opportunities
• Expansion into emerging markets
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Sodium Phenylbutyrate Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Sodium Phenylbutyrate Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pharmaceutical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Food & Beverages
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Sodium Phenylbutyrate Market, By Distribution Channel, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Direct Sales
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Distributor Sales
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Online Retail
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Sodium Phenylbutyrate Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Food & Beverage Industry
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cosmetic Industry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Other Industries
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Sodium Phenylbutyrate Market , By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • South Africa
    • North Africa
    • Central Africa
    • Rest of Middle East

9. Competitive Landscape

• Horizon Therapeutics plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ammonett Pharma LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Medison Pharma Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Synageva BioPharma Corp.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Swedish Orphan Biovitrum AB (Sobi)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Entera Health, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Dipharma Francis S.r.I.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Uncyclyd Pharma, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us